Expression of Epithelial-Mesenchymal Transition Proteins in Pancreatic Anaplastic (Undifferentiated) Carcinoma

Objectives The aim of this study was to identify an association of pancreatic anaplastic carcinoma (APC) with the epithelial-mesenchymal transition (EMT). Methods Resected APCs (n = 24) were examined to assess components of APCs, including carcinomatous, transitional, and sarcomatous regions. Analysis was performed based on the immunoreactivity of E-cadherin and 3 EMT-related proteins: Slug (zinc finger protein SNAI2), Twist (Twist-related protein 1), and Zeb1 (zinc finger E-box–binding homeobox 1). Expression score was determined based on staining intensity and stained area of the target cells. Finally, we performed a hierarchical clustering based on the expression pattern of E-cadherin and EMT-related proteins of the sarcomatous component. Results The expression score of E-cadherin decreased in the order of sarcomatous > transitional > carcinomatous components (P < 0.01). Although there were significant differences in the immunohistochemical scores of Slug, Twist, and Zeb1 between carcinomatous and transitional components (P < 0.01), the significant difference in immunohistochemical score of Zeb1 between transitional and sarcomatous components was found (P < 0.05). Furthermore, APCs were divided into 2 subgroups based on the expression patterns of E-cadherin and EMT-related proteins (hierarchical clustering analysis). Consequently, these subgroups were distinguished by Twist expression. Conclusions Epithelial-mesenchymal transition plays an essential role in the pathogenesis of APC.

[1]  F. Bruyère,et al.  Clinical significance of epithelial-mesenchymal transition markers in prostate cancer. , 2017, Human pathology.

[2]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[3]  A. Piotrowska,et al.  Expression of EMT Markers SLUG and TWIST in Breast Cancer. , 2015, Anticancer research.

[4]  Bao-feng Xu,et al.  CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma , 2015, Tumor Biology.

[5]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[6]  Min Zhao,et al.  Expression and correlation of Twist and gelatinases in breast cancer , 2013, Experimental and therapeutic medicine.

[7]  A. Postigo,et al.  ZEB1 Promotes Invasiveness of Colorectal Carcinoma Cells through the Opposing Regulation of uPA and PAI-1 , 2013, Clinical Cancer Research.

[8]  W. Harmsen,et al.  Clinical outcomes for anaplastic pancreatic cancer: a population-based study. , 2012, Journal of the American College of Surgeons.

[9]  X. Chen,et al.  Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. , 2011, Gastroenterology.

[10]  A. G. de Herreros,et al.  Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.

[11]  M. Büchler,et al.  Anaplastic pancreatic cancer: Presentation, surgical management, and outcome. , 2011, Surgery.

[12]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[13]  Meenakshi Singh,et al.  ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease , 2008, Modern Pathology.

[14]  M. Gönen,et al.  Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer , 2007, Journal of Gastrointestinal Surgery.

[15]  Héctor Peinado,et al.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.

[16]  Michael A. Choti,et al.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience , 2006, Journal of Gastrointestinal Surgery.

[17]  K. Horwitz,et al.  The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers. , 2006, Cancer research.

[18]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[19]  M. Nieto,et al.  The Snail genes as inducers of cell movement and survival: implications in development and cancer , 2005, Development.

[20]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[21]  J. Kriegsmann,et al.  Osteoclast-like giant cell tumor of the pancreas with ductal adenocarcinoma: case report with novel data on histogenesis. , 2002, Pancreas.

[22]  E. Paal,et al.  A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. , 2001, Annals of diagnostic pathology.

[23]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[24]  G. Klöppel,et al.  The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas , 1998, Virchows Archiv.

[25]  K. Yamaguchi,et al.  Pleomorphic carcinoma of the pancreas: reappraisal of surgical resection , 1998, American Journal of Gastroenterology.

[26]  C. Heffess,et al.  Undifferentiated carcinoma with osteoclast‐like giant cells of the pancreas and periampullary region , 1998, Cancer.

[27]  E. Hay An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[28]  A. Moossa,et al.  Survival in 1001 patients with carcinoma of the pancreas. , 1987, Annals of surgery.

[29]  S. Sommers,et al.  Unusual carcinomas of the pancreas. , 1954, A.M.A. archives of pathology.